Randomized Intergroup Comparison of Bacillus Calmette-Guerin Immunotherapy and Mitomycin C Chemotherapy Prophylaxis in Superficial Transitional Cell Carcinoma of the Bladder - A Southwest Oncology Group Study

Author： Lamm D.L.   Blumenstein B.A.   Crawford E.D.   Crissman J.D.   Lowe B.A.   Smith J.A.   Sarosdy M.F.   Schellhammer P.F.   Sagalowsky A.I.   Messing E.M.   Loehrer P.   Grossman H.B.  

Publisher： Elsevier

E-ISSN： 1873-2496|1|3|119-126

ISSN： 1078-1439

Source： Urologic Oncology: Seminars and Original Investigations, Vol.1, Iss.3, 1995-05, pp. : 119-126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Enhanced antitumor effect of combination intravesical mitomycin C and bacillus Calmette-Guerin therapy in an orthotopic bladder cancer model

By Matsushima Masashi   Horinaga Minoru   Fukuyama Ryuichi   Yanaihara Hitoshi   Kikuchi Eiji   Kawachi Makoto   Iida Masahiro   Nakahira Yoko   Oya Mototsugu   Asakura Hirotaka  

Oncology Letters, Vol. 2, Iss. 1, 2011-01 ,pp. : 13-19

Spandidos Publications

Access to resources Recommend Favorite

Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients

By Milla Paola   Fiorito Chiara   Soria Francesco   Arpicco Silvia   Cattel Luigi   Gontero Paolo  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 503-509

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic Value of Bcl-2 and Bax Tumor Cell Expression in Patients with Non Muscle-Invasive Bladder Cancer Receiving Bacillus Calmette-Guerin Immunotherapy

By Ajili Faouzia   Kaabi Belhassen   Darouiche Amine   Tounsi Haifa   Kourda Nadia   Chebil Mohamed   Manai Mohamed   Boubaker Samir  

Ultrastructural Pathology, Vol. 36, Iss. 1, 2012-08 ,pp. : 31-39

Informa Healthcare

Access to resources Recommend Favorite

Tumor Multiplicity Is an Independent Prognostic Factor of Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guerin Immunotherapy

By Ajili Faouzia   Manai Mohamed   Darouiche Amine   Chebil Mohamed   Boubaker Samir  

Ultrastructural Pathology, Vol. 36, Iss. 5, 2012-10 ,pp. : 320-324

Informa Healthcare

Access to resources Recommend Favorite

Differential C-erbB-2 and VEGF expression following BCG immunotherapy in superficial papillary transitional cell carcinoma of the bladder

By Morgan B.E.   Salup R.   Morgan M.B.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 67-72

Elsevier

Access to resources Recommend Favorite